KCG
NVS icon

Knight Capital Group’s Novartis NVS Stock Holding History

Knight Capital Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$665K Buy
+10,490
New +$683K 0.01% 1425

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Knight Capital Group's NVS Position: Q2 2013 in Review

Knight Capital Group opened a new position in Novartis (NVS) in Q2 2013: 20,792 shares worth $1.32M. The stake represents 0.02% of the portfolio and ranks #802 among its holdings.

763 funds tracked by Wall St. Rank hold NVS as of Q2 2013.

  • Knight Capital Group held 20,792 shares of Novartis worth $1.32M as of Q2 2013.
  • Novartis was a new Knight Capital Group position in Q2 2013.
  • Novartis made up 0.02% of Knight Capital Group's portfolio in Q2 2013, its #802 holding.
  • 763 funds tracked by Wall St. Rank held Novartis as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.